New Clinical Studies Confirm Mauna Kea Technologies’ Cellvizio(R) GI In Range Of Procedures (Medical News Today)
New Clinical Studies Confirm Mauna Kea Technologies’ Cellvizio(R) GI In Range Of Procedures (Medical News Today)
Mauna Kea Technologies (MKT), the leader in the field of in vivo cellular imaging, announced that leading European gastroenterologists presented five abstracts related to the company’s Cellvizio(R) GI at the 15th United European Gastroenterology Week (UEGW). [click link for full article]